US4154863A
(en)
*
|
1977-01-28 |
1979-05-15 |
Rich Products Corporation |
Intermediate moisture, ready-to-use, frozen foods
|
US4444755A
(en)
*
|
1978-01-23 |
1984-04-24 |
Efamol Limited |
Treatment for skin disorders
|
EP0004770B1
(en)
*
|
1978-04-11 |
1984-06-13 |
Efamol Limited |
Pharmaceutical and dietary composition comprising gamma-linolenic acids
|
US4386072A
(en)
*
|
1981-06-26 |
1983-05-31 |
Horrobin David F |
Treatment of disorders of inflammation and immunity and disorders associated with smooth muscle spasm and compositions therefor
|
EP0179959A1
(en)
*
|
1982-04-20 |
1986-05-07 |
Merck Frosst Canada Inc. |
Conjugates of leukotrienes with proteins
|
EP0093516B1
(en)
*
|
1982-04-29 |
1986-10-01 |
Efamol Limited |
Pharmaceutical composition
|
GB8302708D0
(en)
*
|
1983-02-01 |
1983-03-02 |
Efamol Ltd |
Pharmaceutical and dietary composition
|
US4560514A
(en)
*
|
1984-05-04 |
1985-12-24 |
Bengt Samuelsson |
Inflammatory lipoxin A and anti-anflammatory lipoxin B compounds
|
US4576758A
(en)
*
|
1984-06-01 |
1986-03-18 |
The Upjohn Company |
Anti-inflammatory lipoxin B analogs
|
GB8425006D0
(en)
*
|
1984-10-03 |
1984-11-07 |
Efamol Ltd |
Composition of copper/fatty acids
|
GB8507058D0
(en)
*
|
1985-03-19 |
1985-04-24 |
Efamol Ltd |
Pharmaceutical & dietary compositions
|
GB8524276D0
(en)
*
|
1985-10-02 |
1985-11-06 |
Efamol Ltd |
Pharmaceutical & dietary compositions
|
US5073561A
(en)
*
|
1987-03-31 |
1991-12-17 |
Warner-Lambert Company |
Methods of treating depression and psychoses
|
US4918104A
(en)
*
|
1987-06-16 |
1990-04-17 |
Weiss Howard S |
Method and composition for increasing the concentration of omega-3 polyunsaturated fatty acids in poultry and poultry eggs and poultry and eggs resulting therefrom
|
FR2618332B1
(fr)
*
|
1987-07-23 |
1990-04-27 |
Synthelabo |
Emulsion lipidique destinee a la nutrition parenterale ou enterale
|
US5069903A
(en)
*
|
1987-12-16 |
1991-12-03 |
Stitt Paul A |
Therapeutic and nutritive flax seed composition and methods employing the same
|
DE68924714T2
(de)
*
|
1988-01-14 |
1996-05-02 |
Anders Frithz |
Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
|
GB8813766D0
(en)
*
|
1988-06-10 |
1988-07-13 |
Efamol Holdings |
Essential fatty acid compositions
|
GB8819110D0
(en)
*
|
1988-08-11 |
1988-09-14 |
Norsk Hydro As |
Antihypertensive drug & method for production
|
US5130242A
(en)
*
|
1988-09-07 |
1992-07-14 |
Phycotech, Inc. |
Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids
|
US5340742A
(en)
*
|
1988-09-07 |
1994-08-23 |
Omegatech Inc. |
Process for growing thraustochytrium and schizochytrium using non-chloride salts to produce a microfloral biomass having omega-3-highly unsaturated fatty acids
|
IE63225B1
(en)
*
|
1988-09-13 |
1995-04-05 |
Efamol Holdings |
Use of fatty acids in the treatment of myalgic encephalomyelitis
|
US5059622A
(en)
*
|
1989-08-29 |
1991-10-22 |
Biosyn, Inc. |
Method for reducing blood pressure levels in hypertensive persons
|
US6140304A
(en)
*
|
1988-09-28 |
2000-10-31 |
Eicotech Corporation |
Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia
|
CH676909A5
(es)
*
|
1988-12-23 |
1991-03-28 |
Nestle Sa |
|
CA2058930C
(en)
*
|
1989-06-14 |
2000-08-15 |
John C. Cox (Deceased) |
Media for cell growth and method for making them
|
GB8918294D0
(en)
*
|
1989-08-10 |
1989-09-20 |
Efamol Holdings |
Pharmaceutical compositions
|
FR2652588A1
(fr)
*
|
1989-10-04 |
1991-04-05 |
Medgenix Group Sa |
Procede de production d'un melange de glycerides enrichis en acides gras.
|
GB9001121D0
(en)
*
|
1990-01-18 |
1990-03-21 |
Efamol Holdings |
Efa compositions and therapy
|
US5407957A
(en)
*
|
1990-02-13 |
1995-04-18 |
Martek Corporation |
Production of docosahexaenoic acid by dinoflagellates
|
US5244921A
(en)
*
|
1990-03-21 |
1993-09-14 |
Martek Corporation |
Eicosapentaenoic acids and methods for their production
|
JP2611852B2
(ja)
*
|
1990-04-17 |
1997-05-21 |
富士写真フイルム株式会社 |
ハロゲン化銀写真感光材料
|
DK0457950T3
(da)
*
|
1990-05-23 |
1994-03-07 |
Nestle Sa |
Anvendelse af stearidonsyre til behandling af inflammatorisk betingede sygdomme
|
GB9012651D0
(en)
*
|
1990-06-06 |
1990-07-25 |
Efamol Holdings |
Essential fatty acid treatment
|
US5472841A
(en)
*
|
1990-06-11 |
1995-12-05 |
Nexstar Pharmaceuticals, Inc. |
Methods for identifying nucleic acid ligands of human neutrophil elastase
|
CA2101274C
(en)
*
|
1991-01-24 |
1998-12-15 |
David J. Kyle |
Microbial oil mixtures and uses thereof
|
JP2696613B2
(ja)
*
|
1991-03-08 |
1998-01-14 |
美穂 田中 |
養魚用飼料とその製造法
|
JPH04121282U
(ja)
*
|
1991-04-15 |
1992-10-29 |
日本メジフイジツクス株式会社 |
試薬供給器
|
SE9101642D0
(sv)
*
|
1991-05-30 |
1991-05-30 |
Kabi Pharmacia Ab |
Phospholipids
|
GB9111900D0
(en)
*
|
1991-06-03 |
1991-07-24 |
Efamol Holdings |
Fatty acid compositions
|
GB9112052D0
(en)
*
|
1991-06-05 |
1991-07-24 |
Efamol Holdings |
Fatty acid treatment
|
DE4133694C2
(de)
*
|
1991-10-11 |
1993-10-07 |
Fresenius Ag |
Verwendung einer Emulsion mit mehrfach ungesättigten Fettsären zur i.v.-Verabreichung zur Behandlung von Hauterkrankungen
|
FR2686619B1
(fr)
*
|
1992-01-28 |
1995-07-13 |
Commissariat Energie Atomique |
Procede de production selective de lipides poly-insatures a partir d'une culture de micro-algues du type porphyridium et cuve utilisee dans ce procede.
|
SE9200541D0
(sv)
*
|
1992-02-24 |
1992-02-24 |
Kabi Pharmacia Ab |
New usee of omega-3-fatty acids
|
US5223285A
(en)
*
|
1992-03-31 |
1993-06-29 |
Abbott Laboratories |
Nutritional product for pulmonary patients
|
US5674901A
(en)
*
|
1995-06-01 |
1997-10-07 |
Wisconsin Alumni Research Foundation |
Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations
|
US5430066A
(en)
*
|
1992-04-29 |
1995-07-04 |
Wisconsin Alumni Research Foundation |
Methods for preventing weight loss, reduction in weight gain, and anorexia due to immune stimulation
|
US5683898A
(en)
*
|
1992-05-15 |
1997-11-04 |
Sagami Chemical Research Center |
Gene coding for eicosapentaenoic acid synthesizing enzymes and process for production of eicosapentaenoic acid
|
GB9211229D0
(en)
*
|
1992-05-27 |
1992-07-08 |
Efamol Holdings |
Fatty acid treatment
|
US5422371A
(en)
*
|
1992-05-27 |
1995-06-06 |
Arch Development Corp. |
Methods and compositions for inhibiting 5α-reductase activity
|
US5516801A
(en)
*
|
1992-08-21 |
1996-05-14 |
Scotia Holdings Plc |
Fatty acid treatment for ectopic calcium deposition
|
GB9217780D0
(en)
*
|
1992-08-21 |
1992-10-07 |
Efamol Holdings |
Fatty acid treatment
|
US5888541A
(en)
*
|
1992-08-21 |
1999-03-30 |
Scotia Holdings Plc |
Fatty acid treatment
|
GB9218064D0
(en)
*
|
1992-08-25 |
1992-10-14 |
Efamol Holdings |
Method for the safe intravenous administration of fatty acids
|
JPH06141886A
(ja)
*
|
1992-11-06 |
1994-05-24 |
Nippon Paper Ind Co Ltd |
高温耐性及び消化吸収性の改善されたファフィア・ロドチーマによるアスタキサンチンの生産方法
|
DE4238869C2
(de)
|
1992-11-18 |
1994-09-08 |
Wogepharm Gmbh |
Mittel zur Behandlung des atopischen Ekzems und anderer entzündlicher Hautkrankheiten
|
GB9224809D0
(en)
*
|
1992-11-26 |
1993-01-13 |
Scotia Holdings Plc |
Schizophrenia
|
GB9301446D0
(en)
*
|
1993-01-26 |
1993-03-17 |
Scotia Holdings Plc |
Internal radiation damage
|
AU683027B2
(en)
*
|
1993-01-27 |
1997-10-30 |
Scotia Holdings Plc |
Triglycerides
|
CA2119000A1
(en)
*
|
1993-03-19 |
1994-09-20 |
David Frederick Horrobin |
Formulation for use in smokers
|
US20050027004A1
(en)
|
1993-06-09 |
2005-02-03 |
Martek Biosciences Corporation |
Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
|
US5411988A
(en)
*
|
1993-10-27 |
1995-05-02 |
Bockow; Barry I. |
Compositions and methods for inhibiting inflammation and adhesion formation
|
FR2722410B1
(fr)
*
|
1994-07-15 |
1996-10-04 |
Grinda Jean Robert |
Procede de stabilisation des acides gras poly-insatures et utilisation de ces produits stabilises entherapeutique
|
US5660842A
(en)
*
|
1994-10-04 |
1997-08-26 |
Bristol-Myers Squibb Company |
Inhibition of helicobacter
|
EP0711503A3
(en)
|
1994-11-14 |
1997-11-26 |
Scotia Holdings Plc |
Milk fortified with GLA and/or DGLA
|
GB9423625D0
(en)
|
1994-11-23 |
1995-01-11 |
Scotia Holdings Plc |
Fortified fruit juice
|
GB9509764D0
(en)
*
|
1995-05-15 |
1995-07-05 |
Tillotts Pharma Ag |
Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
|
GB9510636D0
(en)
*
|
1995-05-25 |
1995-07-19 |
Scotia Holdings Plc |
Fatty acid treatment
|
AU716372C
(en)
|
1995-07-04 |
2001-07-26 |
Suntory Holdings Limited |
Food composition containing an omega-6/omega-3 unsaturated fatty acid balance modifier
|
GB9519661D0
(en)
*
|
1995-09-27 |
1995-11-29 |
Scotia Holdings Plc |
Fatty acid treatment
|
US6255505B1
(en)
|
1996-03-28 |
2001-07-03 |
Gist-Brocades, B.V. |
Microbial polyunsaturated fatty acid containing oil from pasteurised biomass
|
JP2000509079A
(ja)
|
1996-04-11 |
2000-07-18 |
ロダース・クロックラーン・ビー・ブイ |
自由流動性脂肪組成物
|
US6340485B1
(en)
*
|
1996-06-03 |
2002-01-22 |
Croda International Plc |
Compositions and uses thereof
|
GB9617847D0
(en)
*
|
1996-08-27 |
1996-10-09 |
Scotia Holdings Plc |
Fatty acid treatment
|
GB9618420D0
(en)
|
1996-09-04 |
1996-10-16 |
Scotia Holdings Plc |
Fatty acid treatment
|
DE69720787T2
(de)
*
|
1996-10-11 |
2004-03-18 |
Scarista Ltd., Douglas |
Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure
|
JP4633204B2
(ja)
*
|
1996-10-11 |
2011-02-16 |
サントリーホールディングス株式会社 |
アラキドン酸含有食用油脂およびそれを含有する食品
|
US8828432B2
(en)
|
1996-10-28 |
2014-09-09 |
General Mills, Inc. |
Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
|
US5843919A
(en)
*
|
1996-11-25 |
1998-12-01 |
Burger; John A. |
Composition and method for the treatment of arthritis
|
US5855917A
(en)
*
|
1996-12-04 |
1999-01-05 |
Wisconsin Alumni Research Foundation |
Method for controlling body fat and/or body weight in animals and pharmaceutical compositions for use therein comprising 20-carbon conjugated unsaturated fatty acids
|
US6344482B1
(en)
*
|
1997-04-23 |
2002-02-05 |
Andrew L. Stoll |
Omega-3 fatty acids in the treatment of bipolar disorder
|
US5993221A
(en)
*
|
1997-05-01 |
1999-11-30 |
Beth Israel Deaconess Medical Center, Inc. |
Dietary formulation comprising arachidonic acid and methods of use
|
GB9715444D0
(en)
*
|
1997-07-22 |
1997-09-24 |
Scotia Holdings Plc |
Therapeutic and dietary compositions
|
WO1999006585A1
(en)
|
1997-08-01 |
1999-02-11 |
Martek Biosciences Corporation |
Dha-containing nutritional compositions and methods for their production
|
BR9812276B1
(pt)
*
|
1997-08-14 |
2013-10-29 |
|
Método para aumentar a quantidade de um ácido graxo altamente insaturado (hufa) ômega-3 na carne de aves, e produto alimentício
|
DE19750422C1
(de)
|
1997-11-14 |
1998-11-26 |
Henkel Kgaa |
Verwendung von ausgewählten Phytostenolestern zur Herstellung von hypocholesterinämischen Mitteln
|
US20030152983A1
(en)
|
1997-12-23 |
2003-08-14 |
University Of Bristol |
Desaturase
|
ES2201673T3
(es)
|
1998-02-11 |
2004-03-16 |
Rtp Pharma Corporation |
Combinacion de esteroides y acidos grasos poiinsaturados para el tratamiento de estados inflamatorios.
|
US7138431B1
(en)
|
1998-02-23 |
2006-11-21 |
Wake Forest University |
Dietary control of arachidonic acid metabolism
|
US6107334A
(en)
*
|
1998-02-23 |
2000-08-22 |
Wake Forest University |
Dietary control of arachidonic acid metabolism
|
DE69941212D1
(de)
|
1998-03-23 |
2009-09-17 |
Gen Mills Inc |
Verkapselung von komponenten in essbaren produkten
|
IT1304406B1
(it)
*
|
1998-10-21 |
2001-03-19 |
Danital Italia S R L |
Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3.
|
EP1027831B1
(fr)
*
|
1999-02-12 |
2005-10-12 |
Societe Des Produits Nestle S.A. |
Composition lipidique stabilisée, procédé de préparation et produit nutritionnel la contenant
|
CA2362515C
(en)
*
|
1999-03-04 |
2008-07-15 |
Suntory Limited |
Utilization of material containing docosapentaenoic acid
|
US20050037065A1
(en)
|
1999-05-27 |
2005-02-17 |
Drugtech Corporation |
Nutritional formulations
|
US6258846B1
(en)
*
|
1999-06-01 |
2001-07-10 |
Drugtech Corporation |
Nutritional supplements
|
GB9916536D0
(en)
|
1999-07-14 |
1999-09-15 |
Scarista Limited |
Nutritional or pharmaceutical compositions
|
JP4669095B2
(ja)
*
|
1999-07-19 |
2011-04-13 |
太陽化学株式会社 |
ペットの問題行動抑制組成物
|
CA2347094C
(en)
|
1999-08-13 |
2015-02-03 |
Suntory Limited |
Microorganisms that extracellularly secrete lipids and methods of producing lipid and lipid vesicles encapsulating lipids using said microorganisms
|
EP1211955A1
(en)
|
1999-08-30 |
2002-06-12 |
Ocean Nutrition Canada Ltd. |
A nutritional supplement for lowering serum triglyceride and cholesterol levels
|
US6340705B1
(en)
*
|
1999-09-10 |
2002-01-22 |
Monsanto Technology, Llc |
Use of α-linolenic acid metabolites for treatment or prevention of cancer
|
AU784123B2
(en)
|
1999-10-13 |
2006-02-09 |
Marco A. Chacon |
Therapeutic intervention to mimic the effect of caloric restriction
|
US6737078B1
(en)
|
1999-11-24 |
2004-05-18 |
The Iams Company |
Process for enhancing canine and feline reproductive performance
|
US20010047036A1
(en)
|
1999-12-17 |
2001-11-29 |
Vanderhoof Jon A. |
Composition for improving the proliferative response during adaptation of the gastrointestinal tract and use in short bowel syndrome
|
US20020146400A1
(en)
|
2000-01-07 |
2002-10-10 |
Cincotta Anthony H. |
Composition for reducing plasma triglycerides, platelet aggregation, and oxidative capacity
|
EP2295594B1
(en)
|
2000-01-19 |
2018-04-04 |
DSM IP Assets B.V. |
Solventless extraction process
|
US6277417B1
(en)
*
|
2000-04-07 |
2001-08-21 |
Triarco Industries, Inc. |
Method of inhibiting 5α-reductase with astaxanthin
|
US7226916B1
(en)
|
2000-05-08 |
2007-06-05 |
N.V. Nutricia |
Preparation for the prevention and/or treatment of vascular disorders
|
US7208180B2
(en)
|
2000-05-08 |
2007-04-24 |
N.V. Nutricia |
Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
|
DE60125176T3
(de)
|
2000-06-26 |
2015-07-23 |
Dsm Ip Assets B.V. |
Verbesserte Verfahren zum Hinzufügen mehrfach gesättigter Fettsäuren in Milch
|
US6407705B1
(en)
*
|
2000-06-27 |
2002-06-18 |
Mohamed Said Sanad |
Compact broadband high efficiency microstrip antenna for wireless modems
|
GB0016045D0
(en)
*
|
2000-06-29 |
2000-08-23 |
Laxdale Limited |
Therapeutic combinations of fatty acids
|
EP1178118A1
(en)
*
|
2000-08-02 |
2002-02-06 |
Dsm N.V. |
Isolation of microbial oils
|
JP2002047176A
(ja)
|
2000-08-04 |
2002-02-12 |
Idemitsu Technofine Co Ltd |
IgE産生抑制剤
|
ES2220800T3
(es)
|
2000-08-10 |
2004-12-16 |
Ocean Nutrition Canada Ltd. |
Preparaciones de chlorella que muestran propiedades inmunomoduladoras.
|
US6667064B2
(en)
|
2000-08-30 |
2003-12-23 |
Pilot Therapeutics, Inc. |
Composition and method for treatment of hypertriglyceridemia
|
US20040037892A1
(en)
|
2001-11-19 |
2004-02-26 |
Adrianne Bendich |
Dietary composition containing conjugated linoleic acid and calcium for improved health
|
CN1218035C
(zh)
*
|
2000-12-11 |
2005-09-07 |
姜悦 |
利用海洋微藻异养培养生产长链多不饱和脂肪酸
|
JP2002209516A
(ja)
|
2001-01-19 |
2002-07-30 |
Nisshin Oil Mills Ltd:The |
食用油脂組成物
|
ITMI20010129A1
(it)
|
2001-01-25 |
2002-07-25 |
Pharmacia & Upjohn Spa |
Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco
|
US6277435B1
(en)
*
|
2001-02-26 |
2001-08-21 |
Martine Lacombe |
Kosher-meat based pet food products
|
ES2324640T3
(es)
|
2001-03-09 |
2009-08-12 |
Societe Des Produits Nestle S.A. |
Aceite que contiene un o unos acido(s) graso(s) poliin-saturado(s) de cadena larga resultante de una biomasa, procedimiento de preparacion, alimento, composicion nutricional, cosmetica o farmaceutica que lo contiene.
|
US7001610B2
(en)
|
2001-04-23 |
2006-02-21 |
Omeganutrel Inc. |
Food supplement and use thereof for elevating levels of essential fatty acids in livestock and products therefrom
|
GB0111282D0
(en)
|
2001-05-09 |
2001-06-27 |
Laxdale Ltd |
Potentiation of therapeutic effects of fatty acids
|
JP4728561B2
(ja)
|
2001-05-14 |
2011-07-20 |
マーテック バイオサイエンシーズ コーポレーション |
植物種子および微生物由来のステアリドン酸およびγ−リノレン酸を含む極性脂質リッチ画分の精製および使用方法
|
MX281182B
(es)
*
|
2001-05-14 |
2010-11-22 |
Martek Biosciences Boulder Corp |
Produccion y uso de una fraccion rica en lipidos polares, que contienen acidos grasos altamente insaturados omega-3 y/u omega-6, procedentes de microbios, de semillas de plantas y de organismos marinos geneticamente modificados.
|
GB0113348D0
(en)
|
2001-06-01 |
2001-07-25 |
Mars Uk Ltd |
Skin diet
|
JP2003048831A
(ja)
|
2001-08-02 |
2003-02-21 |
Suntory Ltd |
脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物
|
US20030032674A1
(en)
|
2001-08-13 |
2003-02-13 |
Hwang Daniel H. |
Use of unsaturated fatty acids to treat severe inflammatory diseases
|
US20050101563A1
(en)
|
2001-08-14 |
2005-05-12 |
Pharmacia Corporation |
Method and compositions for the treatment and prevention of pain and inflammation
|
AU2002323409A1
(en)
|
2001-08-24 |
2003-03-10 |
Martek Biosciences Boulder Corporation |
Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum
|
JP4116844B2
(ja)
|
2001-09-13 |
2008-07-09 |
花王株式会社 |
油脂組成物
|
US6656969B2
(en)
|
2001-09-20 |
2003-12-02 |
Mayo Foundation For Medical Education And Research |
Methods and compositions for inhibiting the proliferation of prostate cancer cells
|
ITMI20012384A1
(it)
|
2001-11-12 |
2003-05-12 |
Quatex Nv |
Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
|
NL1019368C2
(nl)
|
2001-11-14 |
2003-05-20 |
Nutricia Nv |
Preparaat voor het verbeteren van receptorwerking.
|
AU2002352726A1
(en)
|
2001-11-15 |
2003-06-10 |
Galileo Laboratories, Inc. |
Formulations and methods for treatment or amelioration of inflammatory conditions
|
US8729124B2
(en)
|
2002-03-05 |
2014-05-20 |
Pronova Biopharma Norge As |
Use of EPA and DHA in secondary prevention
|
EP1489915A4
(en)
|
2002-03-08 |
2005-09-14 |
Monsanto Technology Llc |
TREATMENT AND PREVENTION OF INFLAMMATORY DISORDERS
|
US20030175403A1
(en)
|
2002-03-14 |
2003-09-18 |
Gurin Michael H. |
Potentiated bioactive additives and method of use
|
US7396548B2
(en)
|
2002-03-19 |
2008-07-08 |
Advanced Bionutrition Corporation |
Microalgal feeds containing arachidonic acid and their production and use
|
US20030203004A1
(en)
|
2002-04-24 |
2003-10-30 |
Kelm Gary Robert |
Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight
|
US20030215465A1
(en)
|
2002-04-25 |
2003-11-20 |
Lc Usa Llc |
Use of conjugated acid derivatives
|
EP2266525B1
(en)
|
2002-05-03 |
2012-07-11 |
Martek Biosciences Corporation |
High quality lipids and methods for producing by enzymatic liberation from biomass
|
FR2839887A1
(fr)
|
2002-05-22 |
2003-11-28 |
Synergia |
Nouvelles compositions nutraceutiques et pharmaceutiques et leurs utilisations
|
EP2368445A1
(en)
|
2002-06-18 |
2011-09-28 |
Martek Biosciences Corporation |
Stable Emulsions of Oils in Aqueous Solutions and Methods for Producing Same
|
US20040001874A1
(en)
|
2002-06-24 |
2004-01-01 |
Vital Living, Inc. |
Safe and effective nutritional supplement formulations and associated regimens adapted to prevent and/or treat targeted diseases or medical or health conditions, and related methods
|
AU2003247685A1
(en)
|
2002-07-02 |
2004-01-23 |
Galileo Pharmaceuticals, Inc. |
Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
|
US20040132819A1
(en)
|
2002-08-06 |
2004-07-08 |
Nancy Auestad |
Appetite control method
|
EP1388295A1
(en)
|
2002-08-07 |
2004-02-11 |
Nestec S.A. |
Cereal based food product comprising DHA
|
US7410663B2
(en)
|
2002-08-07 |
2008-08-12 |
Kao Corporation |
Oil or fat composition
|
DK1396533T3
(da)
|
2002-09-04 |
2009-01-12 |
Nestec Sa |
Fremgangsmåde til fremstilling af en olie indeholdende en eller flere polyumættede langkædede fedtsyrer ud fra biomasse, næringsmiddel samt nærende, kosmetisk eller farmaceutisk sammensætning indeholdende denne
|
GB0221480D0
(en)
|
2002-09-16 |
2002-10-23 |
Laxdale Ltd |
Treatment of anorexia nervosa (AN) and bulimia
|
CN100418519C
(zh)
|
2002-09-24 |
2008-09-17 |
三得利株式会社 |
用于增强认知能力的含有花生四烯酸或其与二十二碳六烯酸的组合的组合物
|
EP1551382A4
(en)
|
2002-09-27 |
2007-01-24 |
Martek Biosciences Corp |
PROPHYLACTIC TREATMENT WITH DOCOSAHEXAENIC ACID FOR PATIENTS WITH SUBCLINIC INFLAMMATION
|
US20040092590A1
(en)
|
2002-09-27 |
2004-05-13 |
Linda Arterburn |
Glycemic control for prediabetes and/or diabetes Type II using docosahexaenoic acid
|
US7445807B2
(en)
|
2002-10-15 |
2008-11-04 |
Western Holdings, Llc |
Agglomerated granular protein-rich nutritional supplement
|
JP2006507306A
(ja)
|
2002-10-31 |
2006-03-02 |
ファスゲン,インク. |
脂肪酸シンターゼ阻害剤による癌の発生を阻害する方法
|
DE10254584A1
(de)
|
2002-11-22 |
2004-06-09 |
HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie |
Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker
|
ES2209658B1
(es)
|
2002-12-05 |
2005-10-01 |
Proyecto Empresarial Brudy, S.L. |
Utilizacion del acido docosahexaenoico como principio activo para el tratamiento de la lipodistrofia.
|
DE10261067A1
(de)
|
2002-12-24 |
2004-08-05 |
Nutrinova Nutrition Specialties & Food Ingredients Gmbh |
Cholesterinsenkendes Mittel, enthaltend eine n-3-Fettsäure
|
CA2516333C
(en)
|
2003-02-21 |
2011-08-23 |
Mochida Pharmaceutical Co., Ltd. |
Drug for reducing side effects in ribavirin / interferon combination therapy
|
US20040235948A1
(en)
|
2003-03-05 |
2004-11-25 |
Solvay Pharmaceuticals Gmbh |
Treatment of diabetic patients with omega-3-fatty acids
|
US20060265766A1
(en)
*
|
2003-03-19 |
2006-11-23 |
Advanced Bionutrition Corporation |
Fish and the production thereof
|
US20070184135A1
(en)
|
2003-03-26 |
2007-08-09 |
Palu Afa K |
Morinda citrifolia-based formulation 5-LOX and 15-LOX
|
US20040191294A1
(en)
|
2003-03-27 |
2004-09-30 |
Ramaprasad Talahalli Ravichandra |
Health composition
|
EP1605930B1
(en)
|
2003-03-27 |
2020-06-03 |
Suntory Holdings Limited |
Use of arachidonic acid for normalization of infradian rhythm
|
DE10317109A1
(de)
|
2003-04-14 |
2004-11-11 |
Cognis Deutschland Gmbh & Co. Kg |
Zubereitungen zur oralen Aufnahme
|
US20040208939A1
(en)
|
2003-04-18 |
2004-10-21 |
Barry Sears |
Novel dietary compositions to reduce inflammation
|
PL2218342T3
(pl)
|
2003-05-27 |
2019-01-31 |
Dsm Ip Assets B.V. |
Nowe kompozycje nutraceutyczne i ich zastosowanie
|
JP4423447B2
(ja)
|
2003-05-28 |
2010-03-03 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
骨粗鬆症予防治療剤
|
DE10324548A1
(de)
|
2003-05-28 |
2004-12-16 |
Nutrinova Nutrition Specialties & Food Ingredients Gmbh |
Diätisches Lebensmittel bei einer gewichtskontrollierenden bzw. gewichtsreduzierenden Ernährung
|
JP4870430B2
(ja)
|
2003-06-20 |
2012-02-08 |
持田製薬株式会社 |
下肢静脈瘤予防・治療用組成物
|
US20070031537A1
(en)
|
2003-06-23 |
2007-02-08 |
Marie-Cristene Secretin |
Infant or follow-on formula
|
WO2005013908A2
(en)
|
2003-08-05 |
2005-02-17 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Neuroprotection protects against cellular apoptosis, neural stroke damage, alzheimer’s disease and retinal degeneration
|
US20050032757A1
(en)
|
2003-08-06 |
2005-02-10 |
Cho Suk H. |
Nutritional supplements
|
US20050032892A1
(en)
|
2003-08-07 |
2005-02-10 |
The Procter & Gamble Company |
Compositions, kits, and methods for treating gastrointestinal conditions
|
WO2005018630A1
(en)
|
2003-08-11 |
2005-03-03 |
Hill's Pet Nutrition, Inc. |
Omega-3 fatty acids for the treatment of canine ostheoarthritis
|
CN1871353B
(zh)
*
|
2003-08-21 |
2013-04-24 |
孟山都技术有限公司 |
来自报春的脂肪酸去饱和酶
|
US20050202063A1
(en)
|
2003-08-26 |
2005-09-15 |
Ebn International Kft |
Food product
|
US20060280776A1
(en)
|
2003-09-02 |
2006-12-14 |
Masafumi Koide |
Diet food
|
US7759507B2
(en)
|
2003-09-05 |
2010-07-20 |
Abbott Laboratories |
Lipid system and methods of use
|
US7396672B2
(en)
|
2003-09-30 |
2008-07-08 |
Tin Yum Joseph Wong |
Method for the production of dinoflagellate cultures
|
WO2005034874A2
(en)
|
2003-10-08 |
2005-04-21 |
The Mclean Hospital Corporation |
Enhanced efficacy of omega-3 fatty acid therapy in the treatment of psychiatric disorders and other indications
|
JP4522075B2
(ja)
|
2003-10-29 |
2010-08-11 |
サントリーホールディングス株式会社 |
血管の老化に起因する症状あるいは疾患の予防又は改善作用を有する組成物
|
BRPI0416403A
(pt)
|
2003-11-28 |
2007-01-09 |
Onbio Corp |
composição de óleo enriquecida em diglicerìdeo com ácido linoléico conjugado
|
SE0303513D0
(sv)
|
2003-12-19 |
2003-12-19 |
Pronova Biocare As |
Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof
|
US20070122452A1
(en)
|
2003-12-22 |
2007-05-31 |
Wakunaga Pharmaceuticla Co., Ltd |
Fat composition
|
EP1711173A2
(en)
|
2003-12-31 |
2006-10-18 |
Igennus Limited |
Formulation containing an eicosapentaenoic acid or an ester thereof and a triterpene or ester thereof
|
US20050154059A1
(en)
|
2004-01-13 |
2005-07-14 |
Cook Mark E. |
Method of treating type III hypersensitive reaction-related diseases and conditions by using conjugated linoleic acid
|
JP4721642B2
(ja)
|
2004-01-20 |
2011-07-13 |
サントリーホールディングス株式会社 |
肝障害を伴う肝臓疾患の予防又は改善剤
|
ITMI20040069A1
(it)
|
2004-01-21 |
2004-04-21 |
Tiberio Bruzzese |
Uso di composizioni di acidi grassi n-3 ad elevata concentrazione per il trattamento di disturbi del sistema nervoso centrale
|
US20060182820A1
(en)
|
2004-02-10 |
2006-08-17 |
Cargill, Incorporated |
Homogeneous Dispersions Containing Citrus Pulp and Applications Thereof
|
EP1731616A4
(en)
|
2004-03-01 |
2011-08-17 |
Suntory Holdings Ltd |
PROCESS FOR THE PRODUCTION OF PHOSPHOLIPID CONTAINING LONG CHAIN POLYUNSATURATED FATTY ACID AS A COMPONENT AND USE THEREOF
|
US8114906B2
(en)
|
2004-04-16 |
2012-02-14 |
Abbott Products Gmbh |
Essential fatty acids in the treatment and/or inhibition of depression in patients with coronary heart or artery disease
|
CN103451246B
(zh)
|
2004-04-22 |
2018-02-16 |
联邦科学技术研究组织 |
用重组细胞合成长链多不饱和脂肪酸
|
EP1750674A4
(en)
|
2004-05-27 |
2012-05-23 |
Advanced Bionutrition Corp |
MICROPARTICLES FOR THE ORAL LEVY
|
US20050266051A1
(en)
|
2004-05-27 |
2005-12-01 |
The Procter & Gamble Company |
Pet food compositions and methods
|
DE602005023308D1
(de)
|
2004-06-04 |
2010-10-14 |
Fluxome Sciences As |
Stoffwechseltechnisch hergestellte zellen zur produktion mehrfach ungesättigter fettsäuren
|
PT1758469E
(pt)
|
2004-06-22 |
2010-02-03 |
Nutricia Nv |
Melhoria da integridade da barreira nos doentes com vih com o uso de ácidos gordos
|
US20070265341A1
(en)
|
2004-07-01 |
2007-11-15 |
The Schepens Eye Research Institute Inc. |
Compositions and methods for treating eye disorders and conditions
|
KR20070040381A
(ko)
|
2004-07-01 |
2007-04-16 |
셰펜스 아이 리써치 |
눈의 장애 및 상태를 치료하는 조성물 및 방법
|
US20080305210A1
(en)
|
2004-07-01 |
2008-12-11 |
General Mills, Inc. |
Cultures Encapsulated With Compound Fat Breakfast Cereals Coated With Compound Fat and Methods of Preparation
|
CA2784420C
(en)
|
2004-07-02 |
2020-11-10 |
Baylor Research Institute |
Glycogen or polysaccharide storage disease treatment method
|
US20060009486A1
(en)
|
2004-07-07 |
2006-01-12 |
Gm Pharmaceuticals Inc. |
Composition and method for treatment and prevention of coronary artery disease
|
FR2873295B1
(fr)
|
2004-07-26 |
2006-12-01 |
Expanscience Sa Lab |
Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation
|
US20060020031A1
(en)
|
2004-07-26 |
2006-01-26 |
Roger Berlin |
Compositions containing policosanol and omega-3 fatty acids and their pharmaceutical uses
|
WO2006017627A2
(en)
|
2004-08-06 |
2006-02-16 |
Barry Sears |
Dietary compositions comprising docosahexaenoic acid and eicosapentaenoic acid and use thereof for treating insulin resistance
|
TW200626134A
(en)
|
2004-09-10 |
2006-08-01 |
Pronova Biocare A S |
Treatment of IgA nephropathy with Omega-3 fatty acids
|
JP2006083136A
(ja)
|
2004-09-17 |
2006-03-30 |
Suntory Ltd |
ストレスに起因する脳機能の低下およびそれに伴う症状あるいは疾患の予防又は改善作用を有する組成物
|
US7550286B2
(en)
*
|
2004-11-04 |
2009-06-23 |
E. I. Du Pont De Nemours And Company |
Docosahexaenoic acid producing strains of Yarrowia lipolytica
|
EP1656934A1
(en)
|
2004-11-12 |
2006-05-17 |
Cognis IP Management GmbH |
Use of physiologically active fatty acids for treating lipodystrophy
|
WO2006054316A1
(en)
|
2004-11-16 |
2006-05-26 |
Magene Life Sciences Private Limited |
Method(s) of preparation, stabilization, composition, and administration of gamma-linolenic acid for brain tumors
|
US7893106B2
(en)
|
2004-11-19 |
2011-02-22 |
Martek Biosciences, Corporation |
Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same
|
FR2878747B1
(fr)
|
2004-12-03 |
2007-03-30 |
Pierre Fabre Medicament Sa |
Utilisation d'acide(s) gras omega-3 pour le traitement de l'hypercholesterolemie causee par un traitement anti-retroviral chez les patients infectes par le vih
|
CN101098690A
(zh)
|
2004-12-06 |
2008-01-02 |
瑞莱恩特医药品有限公司 |
用于血脂治疗的ω-3脂肪酸和脂血异常剂
|
US20070191467A1
(en)
|
2004-12-06 |
2007-08-16 |
Reliant Pharmaceutical, Inc. |
Statin and omega-3 fatty acids for lipid therapy
|
EA014420B1
(ru)
|
2004-12-06 |
2010-12-30 |
Релайэнт Фармасьютикалз, Инк. |
Омега-3 жирные кислоты и дислипидемический агент для липидной терапии
|
GB2421909A
(en)
|
2004-12-23 |
2006-07-12 |
Laxdale Ltd |
Pharmaceutical compositions comprising EPA and methods of use
|
GB0428384D0
(en)
|
2004-12-24 |
2005-02-02 |
Sla Pharma Ag |
Eicosapentaenoic acid
|
US8324276B2
(en)
|
2005-01-24 |
2012-12-04 |
Pronova Biopharma Norge As |
Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction
|
JP4849806B2
(ja)
|
2005-02-08 |
2012-01-11 |
日本水産株式会社 |
新規な菌体処理方法を用いた高度不飽和脂肪酸の製造方法
|
ITFI20050024A1
(it)
|
2005-02-14 |
2006-08-15 |
Fernando Cantini |
Lipidi per l'alimentazione degli animali
|
EP1858352B1
(en)
|
2005-02-18 |
2013-06-05 |
Delante Health AS |
A composition comprising a powder containing microencapsulated polyunsaturated long-chain esterified fatty acids distributed in an effervescent base
|
US20060211763A1
(en)
|
2005-03-08 |
2006-09-21 |
Abdel Fawzy |
Treatment with Statin and Omega-3 Fatty Acids and a Combination Product Thereof
|
WO2006107736A1
(en)
|
2005-04-01 |
2006-10-12 |
Algaen Corporation |
Extractability and bioavailability of the natural antioxidant astaxanthin from a green alga, haematococcus pluvialis
|
US20060229366A1
(en)
|
2005-04-07 |
2006-10-12 |
Lifschitz Carlos H |
Method for preventing or treating respiratory infections in infants
|
US20060233762A1
(en)
|
2005-04-15 |
2006-10-19 |
Mcmahon Robert J |
Method for treating or preventing systemic inflammation in formula-fed infants
|
EP1714564A1
(en)
|
2005-04-21 |
2006-10-25 |
N.V. Nutricia |
Method for treatment and prevention of respiratory insufficiency
|
WO2006116755A2
(en)
|
2005-04-28 |
2006-11-02 |
Trustees Of Tufts College |
Synergitic effects of docosahexaenoic acid (dha) and carotenoid absorption of cognitive function
|
ES2264886B1
(es)
|
2005-05-12 |
2008-02-01 |
Proyecto Empresarial Brudy, S.L. |
Utilizacion de acido docosahexaenoico para el tratamiento de enfermedades tumorales.
|
US20060270625A1
(en)
|
2005-05-13 |
2006-11-30 |
Eastern Virginia Medical School |
Nutraceuticals for the treatment of neuropathy
|
EP1888081B1
(en)
|
2005-05-23 |
2016-12-28 |
Massachusetts Institute of Technology |
Compositions containing pufa and methods of use thereof
|
US20060292217A1
(en)
|
2005-06-03 |
2006-12-28 |
Schmidt Robbin D |
Nutritional supplement and soft gelatin capsule delivery system
|
WO2006135866A2
(en)
|
2005-06-10 |
2006-12-21 |
Martek Biosciences Corporation |
Pufa polyketide synthase systems and uses thereof
|
DK1896077T3
(da)
|
2005-06-29 |
2012-12-03 |
Hills Pet Nutrition Inc |
Fremgangsmåder og sammensætninger til forebyggelse og behandling af inflammatoriske sygdomme
|
JP5697293B2
(ja)
|
2005-06-30 |
2015-04-08 |
サントリーホールディングス株式会社 |
器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物
|
JP5967855B2
(ja)
|
2005-06-30 |
2016-08-10 |
サントリーホールディングス株式会社 |
日中活動量の低下および/又はうつ症状の改善作用を有する組成物
|
WO2007005725A2
(en)
|
2005-07-01 |
2007-01-11 |
Martek Biosciences Corporation |
Polyunsaturated fatty acid-containing oil product and uses and production thereof
|
RU2444356C2
(ru)
|
2005-07-08 |
2012-03-10 |
Мартек Байосайенсиз Корпорейшн |
Полиненасыщенные жирные кислоты для лечения деменции и состояний, связанных с преддеменцией
|
PL1904044T3
(pl)
|
2005-07-08 |
2013-08-30 |
Sigma Tau Ind Farmaceuti |
Zastosowanie kombinacji obejmującej L- karnitynę lub alkanoilo-L-karnitynę, rozpuszczalny w tłuszczach benzochinon oraz wielonienasycony kwas tłuszczowy omega-3 do wytwarzania suplementu diety lub leku do leczenia chorób rogówki
|
MX2008000915A
(es)
|
2005-07-18 |
2008-04-04 |
Reliant Pharmaceuticals Inc |
Tratamiento con inhibidores de absorcion de colesterol basados en azetidinona y acidos grasos omega-3 y un producto de combinacion de los mismos.
|
US20070020340A1
(en)
|
2005-07-25 |
2007-01-25 |
David Rubin |
Fish oil products for reducing cholesterol, low density lipoprotein, and hypertension
|
ITMI20051560A1
(it)
|
2005-08-10 |
2007-02-11 |
Tiberio Bruzzese |
Composizione di acidi grassi n-3 con elevata concentrazione di epa e-o dha e contenente acidi grassi n-6
|
US7199112B2
(en)
|
2005-08-10 |
2007-04-03 |
William Llewellyn |
Use of phospholipid arachidonic acids for increasing muscle mass in humans
|
US20070042953A1
(en)
|
2005-08-16 |
2007-02-22 |
Bazan Nicolas G |
Antiepileptogenic complex of albumin with docosahexaenoate
|
US20070042008A1
(en)
|
2005-08-18 |
2007-02-22 |
Bodybio, Inc. |
Compositions containing phosphatidylcholine and essential fatty acids
|
JP5371429B2
(ja)
|
2005-08-26 |
2013-12-18 |
ネステク ソシエテ アノニム |
機能的な血管の完全性及び細胞生存を改善し、脳の虚血における又は虚血エピソード後のアポトーシスを減少するための組成物及び方法
|
WO2007029238A2
(en)
|
2005-09-06 |
2007-03-15 |
Oramed Pharmaceuticals, Inc. |
Methods and compositions for oral administration of proteins
|
US20070059340A1
(en)
|
2005-09-09 |
2007-03-15 |
Anthony Bello |
Omega-3 Fatty Acids Encapsulated In Zein Coatings and Food Products Incorporating the Same
|
WO2007035755A2
(en)
|
2005-09-19 |
2007-03-29 |
Duke University |
Methods of treating hematological malignancies
|
BRPI0617175A2
(pt)
|
2005-09-30 |
2011-07-12 |
Nestec Sa |
composições, bem como uso de ácidos graxos poli-insaturados de cadeia longa (lcpufa) na preparação das mesmas, para melhora da função cognitiva
|
PL1940248T3
(pl)
|
2005-10-05 |
2010-05-31 |
Nestec Sa |
Zastosowanie odżywczej formulacji do promowania doganiania wzrostu
|
US20070082063A1
(en)
|
2005-10-11 |
2007-04-12 |
Douglas Bibus |
Risk assessment and correction of membrane damage of the upper GI tract
|
US20070104779A1
(en)
|
2005-11-07 |
2007-05-10 |
Rongen Roelof M |
Treatment with omega-3 fatty acids and products thereof
|
CN103829058A
(zh)
|
2005-11-10 |
2014-06-04 |
希尔氏宠物营养品公司 |
用于改善皮肤健康和毛皮质量的组合物及方法
|
US20070149617A1
(en)
|
2005-11-14 |
2007-06-28 |
Deckelbaum Richard J |
Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs
|
WO2007058523A1
(en)
|
2005-11-17 |
2007-05-24 |
N.V. Nutricia |
Composition with docosapentaenoic acid
|
ES2275435B1
(es)
|
2005-11-18 |
2008-06-01 |
Farmaleis, S.L. |
"composicion farmaceutica que comprende escualeno y uso de la misma para la preparacion de un medicamento para el tratamiento del cancer.
|
FI20051184A0
(fi)
|
2005-11-18 |
2005-11-18 |
Raisio Yhtymae Oyj |
Parannettu rasvakoostumus
|
JP2009519899A
(ja)
|
2005-11-18 |
2009-05-21 |
ヒルズ・ペット・ニュートリシャン・インコーポレーテッド |
動物の組織または体液中の炎症性物質の量を減少させるための方法
|
NO323912B1
(no)
|
2005-12-01 |
2007-07-16 |
Tine Sa |
Sammensetning, fremgangsmåte til fremstilling derav, og anvendelse derav.
|
DE102005058369A1
(de)
|
2005-12-06 |
2007-06-14 |
Lts Lohmann Therapie-Systeme Ag |
Ungesättigte Fettsäuren als Thrombin-Inhibitoren
|
US20070154498A1
(en)
|
2005-12-09 |
2007-07-05 |
Bortz Jonathan D |
Intravenous essential fatty acid emulsion
|
US20070166411A1
(en)
|
2005-12-16 |
2007-07-19 |
Bristol-Myers Squibb Company |
Nutritional supplement containing long-chain polyunsaturated fatty acids
|
EP1968567B1
(en)
|
2005-12-20 |
2014-06-18 |
Cenestra, Llc |
Omega 3 fatty acid formulations
|
AU2006327064B2
(en)
|
2005-12-21 |
2012-04-26 |
Brudy Technology, S.L. |
Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage
|
US20070207975A1
(en)
|
2006-01-10 |
2007-09-06 |
Evanston Northwestern Healthcare |
Materials and methods for treating and preventing Her-2/neu overexpressing, FAS-elevated cancer cells
|
WO2007086931A1
(en)
|
2006-01-24 |
2007-08-02 |
Majid Fotuhi |
Dosage regimen and medicament for preventing of reducing risk of onset or progression of dementia by administration of specific vitamins and nsaid
|
WO2007089685A2
(en)
|
2006-01-30 |
2007-08-09 |
University Of Georgia Research Foundation |
Compositions and methods for inducing adipose tissue cell death
|
US20090320148A1
(en)
|
2006-01-31 |
2009-12-24 |
Martek Biosciences Corporation |
Oxylipins from stearidonic acid and gamma-linolenic acid and methods of making and using the same
|
WO2007100560A2
(en)
|
2006-02-28 |
2007-09-07 |
Bristol-Myers Squibb Company |
Use of dha and ara in the preparation of a composition for inducing the expression of pulmonary surfactant protein-b
|
WO2007100766A2
(en)
|
2006-02-28 |
2007-09-07 |
The Hershey Company |
Health bars and compositions for improving cardiovascular risk factors
|
BRPI0708365A2
(pt)
|
2006-02-28 |
2011-04-26 |
Bristol - Myers Squibb Company |
uso de dha e ara na preparação de uma composição para regular expressão de gene
|
US20070203235A1
(en)
|
2006-02-28 |
2007-08-30 |
Rosales Francisco J |
Method for preventing or treating anemia
|
WO2007100562A2
(en)
|
2006-02-28 |
2007-09-07 |
Bristol-Myers Squibb Company |
Use of dha and ara in the preparation of a composition for reducing triglyceride levels
|
CN101389322A
(zh)
|
2006-02-28 |
2009-03-18 |
布里斯托尔―迈尔斯斯奎布公司 |
二十二碳六烯酸和花生四烯酸在制备用于预防或治疗肥胖症的组合物中的用途
|
JP2009529044A
(ja)
|
2006-03-03 |
2009-08-13 |
モンサント テクノロジー エルエルシー |
心臓血管健康を改善するための手段
|
US20070225370A1
(en)
|
2006-03-21 |
2007-09-27 |
Joar Opheim |
Nutritional Compositions and Methods
|
BRPI0710665A2
(pt)
|
2006-04-03 |
2011-08-16 |
Advanced Bionutrition Corp |
formulações de ração contendo ácido docosa-hexaenóico
|
WO2007121273A2
(en)
|
2006-04-11 |
2007-10-25 |
Martek Biosciences Corporation |
Food products comprising long chain polyunsaturated fatty acids and methods for preparing the same
|
EP2004161B8
(en)
|
2006-04-12 |
2013-04-17 |
Unilever PLC |
Oral composition comprising dha and genistein for enhancing skin properties
|
US20080044487A1
(en)
|
2006-05-05 |
2008-02-21 |
Natural Asa |
Anti-inflammatory properties of marine lipid compositions
|
US20070264222A1
(en)
|
2006-05-10 |
2007-11-15 |
Biohealth Advance, Llc |
Enhanced protection against skin injury in humans
|
EP1886680A1
(en)
|
2006-05-23 |
2008-02-13 |
Nestec S.A. |
Maternal supplement
|
US20070280998A1
(en)
|
2006-06-02 |
2007-12-06 |
Larry Milligan |
Dairy product
|
CN101472612B
(zh)
|
2006-06-14 |
2011-06-08 |
纽崔西亚公司 |
包含甘氨酸和乳铁蛋白的抗炎组合物及其应用
|
CA2655985A1
(en)
|
2006-06-23 |
2007-12-27 |
The Procter & Gamble Company |
Concentrated omega-3 fatty acids and mixtures containing them
|
US20070298079A1
(en)
|
2006-06-26 |
2007-12-27 |
Tropicana Products, Inc. |
Food fortified with omega-3 fatty acids
|
EP2034983A1
(en)
|
2006-06-27 |
2009-03-18 |
Lipid Nutrition B.V. |
Use of a polyunsaturated fatty acid compound
|
CA2656311C
(en)
|
2006-07-05 |
2016-06-21 |
Photonz Corporation Limited |
Ultra pure epa and polar lipids produced in largely heterotrophic culture
|
AU2007271900B2
(en)
|
2006-07-14 |
2013-05-23 |
Nattopharma As |
Pharmaceutical and nutraceutical products comprising vitamin K2
|
JP2009544702A
(ja)
|
2006-07-21 |
2009-12-17 |
リライアント・ファーマシューティカルズ・インコーポレイテッド |
抵抗性高血圧症の治療に使用するオメガ−3脂肪酸
|
JP2009544701A
(ja)
|
2006-07-21 |
2009-12-17 |
リライアント・ファーマシューティカルズ・インコーポレイテッド |
オメガ3脂肪酸を含む組成物、ならびに末梢動脈障害および間欠性跛行を処置するためのそれらの使用
|
US20080031869A1
(en)
|
2006-08-02 |
2008-02-07 |
Fontaine Juliette S |
Pain relief composition
|
FR2904554B1
(fr)
|
2006-08-04 |
2010-11-05 |
Zheng Xu |
Lipides moleculaires heterogenes cytotropes (lmhc), procede de preparation, et methodes de traitement de patients porteurs de cancers multiples
|
AU2007280272A1
(en)
|
2006-08-04 |
2008-02-07 |
Shs International Ltd |
Protein free formula
|
US20080076823A1
(en)
|
2006-08-09 |
2008-03-27 |
Watkins Bruce A |
Methods of improving bone health and muscle health
|
TW200820913A
(en)
|
2006-08-25 |
2008-05-16 |
Martek Biosciences Corp |
Food fortification with polyunsaturated fatty acids
|
EP1897530A1
(en)
|
2006-09-08 |
2008-03-12 |
DSMIP Assets B.V. |
Skin care composition
|
US8410181B2
(en)
|
2006-09-19 |
2013-04-02 |
The Trustees Of Columbia University In The City Of New York |
Omega-3 diglyceride emulsions
|
EP2083813A4
(en)
|
2006-09-26 |
2011-04-27 |
Baylor Res Inst |
NUTRIENT SENSOR
|
US20080085911A1
(en)
|
2006-10-10 |
2008-04-10 |
Reliant Pharmaceuticals, Inc. |
Statin and omega-3 fatty acids for reduction of apo-b levels
|
KR20090086078A
(ko)
|
2006-10-13 |
2009-08-10 |
릴라이언트 파마슈티컬스 인코퍼레이티드 |
항부정맥제 및 오메가-3 지방산 및 이들의 조합 생성물로의 치료
|
US20080125490A1
(en)
|
2006-11-03 |
2008-05-29 |
My Svensson |
Treatment and prevention of cardiovascular disease in patients with chronic kidney disease by administering Omega-3 Fatty Acids
|
US20080118441A1
(en)
|
2006-11-19 |
2008-05-22 |
Washington Joseph A |
Compositions and methods for the treatment of gastrointestinal conditions
|
CA2704371A1
(en)
*
|
2007-11-01 |
2009-05-07 |
Wake Forest University School Of Medicine |
Compositions and methods for prevention and treatment of mammalian diseases
|
CN101260344B
(zh)
*
|
2008-04-22 |
2010-12-15 |
天津大学 |
以微藻油生产二十二碳五烯酸和二十二碳六烯酸混合脂肪酸的方法
|